Results 191 to 200 of about 568,486 (233)
Some of the next articles are maybe not open access.
Ophthalmology, 2012
Brasil OFM, 2007, BRIT J OPHTHALMOL, V91, P761, DOI 10.1136-bjo.2006.105783; Gibran SK, 2007, OPHTHALMOLOGY, V114, P890, DOI 10.1016-j.ophtha.2006.11.026; Kim BY, 2006, AM J OPHTHALMOL, V142, P405, DOI 10.1016-j.ajo.2006.04.023; Shin HJ, 2012, GRAEF ARCH CLIN EXP, V250, P61, DOI 10.1007-s00417-011-1774-x; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15 ...
Nicola G, Ghazi +6 more
+6 more sources
Brasil OFM, 2007, BRIT J OPHTHALMOL, V91, P761, DOI 10.1136-bjo.2006.105783; Gibran SK, 2007, OPHTHALMOLOGY, V114, P890, DOI 10.1016-j.ophtha.2006.11.026; Kim BY, 2006, AM J OPHTHALMOL, V142, P405, DOI 10.1016-j.ajo.2006.04.023; Shin HJ, 2012, GRAEF ARCH CLIN EXP, V250, P61, DOI 10.1007-s00417-011-1774-x; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15 ...
Nicola G, Ghazi +6 more
+6 more sources
2010
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME.
F. Bandello +6 more
+9 more sources
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME.
F. Bandello +6 more
+9 more sources
Persistent diabetic macular edema: Definition, incidence, biomarkers and treatment methods.
Survey of ophthalmology, 2022Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment has drastically improved the visual and anatomical outcomes in patients with diabetic macular edema (DME); however, success is not always guaranteed, and a proportion of these ...
Osama A. Sorour +6 more
semanticscholar +1 more source
Current Opinion in Ophthalmology, 2014
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Fabio, Patelli +2 more
openaire +4 more sources
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Fabio, Patelli +2 more
openaire +4 more sources
International Ophthalmology Clinics, 1976
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
A, Patz, S L, Fine
openaire +2 more sources
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
A, Patz, S L, Fine
openaire +2 more sources
Photocoagulation for Diabetic Macular Edema
Archives of Ophthalmology, 1987To the Editor. —In the December 1985 issue of theArchiveswe published data from the Early Treatment Diabetic Retinopathy Study (ETDRS) that demonstrated that focal photocoagulation of "clinically significant" diabetic macular edema substantially reduces the risk of visual loss. 1 As part of the ongoing monitoring of the 23 clinics in this study, we
L M, Aiello, F L, Ferris
openaire +2 more sources
Quantification of Diabetic Macular Edema
Archives of Ophthalmology, 1987In a cross-sectional study, 34 diabetic patients with clinically significant macular edema underwent visual acuity testing, stereo fundus photography (graded for retinal thickening and hard exudates), fluorescein angiography (evaluated for macular leakage and the outline of the foveal avascular zone [FAZ]), and vitreous fluorophotometry (whereby ...
R T, Smith +4 more
openaire +2 more sources
European Journal of Ophthalmology, 1998
Retinal edema is defined as any increase of water in retinal tissue resulting in an increase in its volume. This increase may be initially intracellular or extracellular. In the first case, there is cytotoxic edema. In the second, vasogenic edema, directly associated with an alteration of the blood-retinal barrier (BRB).
openaire +3 more sources
Retinal edema is defined as any increase of water in retinal tissue resulting in an increase in its volume. This increase may be initially intracellular or extracellular. In the first case, there is cytotoxic edema. In the second, vasogenic edema, directly associated with an alteration of the blood-retinal barrier (BRB).
openaire +3 more sources
Vitrectomy for Diabetic Macular Edema
Ophthalmology, 2010link_to_subscribed_fulltext
Cheung, N, Connell, P, Wong, TY
openaire +3 more sources
Vitrectomy for Diabetic Cystoid Macular Edema
Japanese Journal of Ophthalmology, 2001We evaluated the visual outcome of vitrectomy for diabetic cystoid macular edema.Visual outcome and factors which may influence final visual acuity were assessed and documented retrospectively in 45 eyes of 40 patients, all of whom were followed for at least 6 months postoperatively.Final postoperative visual acuity was two or more lines better than ...
Yukihiro, Sato +2 more
openaire +3 more sources